On a recent âDoctors & Scientistsâ episode on CHD.TV, Childrenâs Health Defenseâs Brian Hooker, Ph.D., and Dr. Meryl Nass discussed the science related to respiratory syncytial virus (RSV) and Big Pharmaâs new RSV immunization agenda.
Respiratory syncytial virus, or RSV, has been dominating the news since the recent approvals by the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) of new RSV vaccines for infants, pregnant women and the elderly.
The new âtherapies ⊠are now sort of a boonâ for Big Pharma, according to Dr. Meryl Nass, internist and member of the Childrenâs Health Defense (CHD) scientific advisory committee.
On a recent âDoctors & Scientistsâ episode on CHD.TV, Brian Hooker, Ph.D., CHDâs senior director of science and research, hosted Nass, who shared a presentation on the science behind RSV and Big Pharmaâs new RSV immunization agenda.
Read Full Article Here…(childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
Â
Live Stream + Chat (zutalk.com)